Quantcast

Latest Pemetrexed Stories

2013-10-16 23:23:56

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - China Drug Forecast and Market Analysis to 2022. London (PRWEB) October 16, 2013 PharmaPoint: Non-Small Cell Lung Cancer - China Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch...

2013-10-03 23:22:52

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022. London (PRWEB) October 03, 2013 PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

2013-09-14 23:03:32

Researchers in The Netherlands say the most popular drug for malignant pleural mesothelioma may not be the most cost-effective drug for the job. Raleigh, NC (PRWEB) September 14, 2013 In a paper published in Anticancer Research and reported by Surviving Mesothelioma, an Amsterdam-based research team reviewed the medical literature on pemetrexed (Alimta), the first FDA-approved drug for mesothelioma, as well as other newer drugs and drug combinations. Although all of the anti-cancer agents...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related